Genetically engineered probiotic for the treatment of phenylketonuria (PKU); assessment of a novel treatment in vitro and in the PAHenu2 mouse model of PKU

The PKU probiotic work, which the NSPKU helped fund, has now been published in PLOS ONE, link below...

http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0176286

Katherine E Durrer will be summarising this work in an article for News & Views.